Protean Select vs UBS Lux Equity Fund Biotech USD

Protean Select vs UBS Lux Equity Fund Biotech USD

1. Protean Select

  • Security

    Protean Select

  • Fee

    2.60%

  • ISIN

    SE0017830748

  • Holdings

    21

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 22 holdings in Protean Select, where the largest holding is RaySearch (4.07), followed by Hexagon (4.04) and Ambea (3.99). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Protean Select and UBS Lux Equity Fund Biotech USD.

Protean Select UBS Lux Equity Fund Biotech USD
1. RaySearch Laboratories B
4.07 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Hexagon B
Sweden
4.04 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Ambea
3.99 %
3. Moderna Inc
9.21 %
4. Nordea Bank Abp
Finland
3.98 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Getinge B
Sweden
3.26 %
5. AbbVie Inc
USA
5.52 %
6. Lindex Group
Finland
3.26 %
6. Gilead Sciences Inc
USA
4.66 %
7. Devyser Diagnostics AB
Sweden
3.18 %
7. Amgen Inc
4.32 %
8. Acast AB
Sweden
3.11 %
8. BioNTech SE
4.13 %
9. Huhtamäki Oyj
Finland
3.1 %
9. Karuna Therapeutics Inc
3.75 %
10. Essity B
Sweden
3.01 %
10. Royalty Pharma Plc
3.28 %
11. Mowi
Norway
3.01 %
-
12. Tryg A/S
Denmark
2.99 %
-
13. Sampo Oyj A
Finland
2.97 %
-
14. Skanska B
Sweden
2.84 %
-
15. Elekta B
Sweden
2.62 %
-
16. Atlas Copco B
Sweden
2.41 %
-
17. MEKO Sweden AB
Sweden
2.29 %
-
18. Coor Service Management Holding
2.21 %
-
19. Lagercrantz Group B
Sweden
2.19 %
-
20. Novo Nordisk B
Denmark
2.08 %
-
21. Indutrade AB
Sweden
2.07 %
-

The list of fund holdings was last updated on April 17, 2025.